1Richardson P, Mckenna W, Bristow M, et al. Report of the 1995 world health organization/in--ternational society and federation of cardiology task force on the definition and classification of car diomyopathies[J]. Circulation, 1996,93(5) :841.
2Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies.-an American Heart Association Scientific Statement from the Council on Clinical Car diology, Heart Failure and Transplantation Committee: Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention [J].Circulation, 2006, 113(14) :1807.
3Slack JM,Tosh D. Transdifferentiation and metaplasia switching cell types[J]. Curr Opin Genet Dev,2001,11(5) ;581.
4Bianco P,Riminucei M,Gronthos S, et al. Bone marrow stromal stem cells: Nature, biology, and potential applications [J]. Stem cells, 2001,19 :180.
5Luk A, Ahn E, Soor GS, Butany J. Dilated cardiomyopathy: a re- view[J]. J Clin Pathol,2009,62(3) :219.
6Noriteshi Nagaya,Kenji Kngawa, el al. Transplantation of Mes- enchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy[J]. Circulation,2005,112(8) : 1128.
8Granero-Molto F,Weis JA, Longobardi L, et al. Role of mesen chymal stem cells in regenerative medicine: application to bone and cartilage repair[J]. Expert Opin Biol Ther, 2008,8(3) : 255.
9In't Anker PS,Scherion SA,Kleijburg-van der Keur C,et al. Am- niotic fluid as a novel source of mesenehymal stem cells for thera peutic transplantation[J]. Blood,2003,102(4) : 1548.
10Iwase T,Nagaya N,Fujii T,et al. Comparison of angiogenic po- teney between mesenchymal stem ceils and mononuclear cells in a rat model of hindlimb ischemia[J]. Cardiovasc Res, 2005,66 (3) :543.
4Minguell J J, Conger P. Erices A. Biology and clinical utilization of mesenchymal progenitor cells [J]. Braz J Med Biol Res. 2000. 33 (8); 881-887.
5Charles E, Mark H, Hans R, et al. Haematopietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts [J]. Nature, 2004 (6893), 428:664-668.
7Makino S, Fukuda K, Miyoshi S, et al, Cardiomyocytes can be generated from marrow stromal cells invitro [J]. J clin Invest, 1999, 103 (5):697-705.
8Lin TXi, Chao C, Saoto S, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression [J]. Nat Cell Biol, 2005, 7 (2): 165-171.
9Kitagawa Y, Kyo S, Takakura M, et al. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT [J]. Clin Cancer Res, 2000. 6 (7): 2868-2875.
10Wei GZ, Theresa H, Yang K, et al. 5-Aza-2'-deoxycytidine Activates the p53/p21^waft/cipl Pathway to inhibit cell proliferation [J]. J Biol Chem, 2004, 279 (15): 15161-15166.
